サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ペットのワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にペットのワクチン市場を分類しています。
本レポートでは世界のペットのワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Bayer Healthcare、Vetoquinol S.A、Boehringer Ingelheim、Ceva、Eli Lilly、Heska Co.、Merck Animal Health、Merial (Sanofi)、Virbac、Zoetis (Pfizer)

レポートはペットのワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。ペットのワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Attenuated Live Vaccines
    Conjugate Vaccines
    Inactivated Vaccines
    Subunit Vaccines
    Toxoid Vaccines
    DNA Vaccines
    Recombinant Vaccines

用途別の市場セグメント：
    Canine
    Avian
    Feline

本レポートの詳細内容
本レポートは、世界のペットのワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてペットのワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のペットのワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、ペットのワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのペットのワクチン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のペットのワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ペットのワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ペットのワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： ペットのワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるペットのワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章ペットのワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：ペットのワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：ペットのワクチンの主要メーカーの概要を提供し、製品の説明と仕様、ペットのワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ペットのワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Pet Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Pet Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Pet Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Pet Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Pet Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pet Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pet Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pet Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc.
Market Segmentation
By Company
    Bayer Healthcare
    Vetoquinol S.A
    Boehringer Ingelheim
    Ceva
    Eli Lilly
    Heska Co.
    Merck Animal Health
    Merial (Sanofi)
    Virbac
    Zoetis (Pfizer)

Segment by Type
    Attenuated Live Vaccines
    Conjugate Vaccines
    Inactivated Vaccines
    Subunit Vaccines
    Toxoid Vaccines
    DNA Vaccines
    Recombinant Vaccines

Segment by Application
    Canine
    Avian
    Feline

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pet Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Pet Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Attenuated Live Vaccines
    Table 3. Major Manufacturers of Conjugate Vaccines
    Table 4. Major Manufacturers of Inactivated Vaccines
    Table 5. Major Manufacturers of Subunit Vaccines
    Table 6. Major Manufacturers of Toxoid Vaccines
    Table 7. Major Manufacturers of DNA Vaccines
    Table 8. Major Manufacturers of Recombinant Vaccines
    Table 9. Global Pet Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Pet Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Pet Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Pet Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 13. Global Pet Vaccine Revenue Market Share by Region (2019-2024)
    Table 14. Global Pet Vaccine Revenue Market Share by Region (2025-2030)
    Table 15. Global Pet Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Pet Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 17. Global Pet Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 18. Global Pet Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Pet Vaccine Sales Market Share by Region (2025-2030)
    Table 20. Global Pet Vaccine Sales by Manufacturers (2019-2024) & (K Doses)
    Table 21. Global Pet Vaccine Sales Share by Manufacturers (2019-2024)
    Table 22. Global Pet Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 23. Global Pet Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 24. Global Key Players of Pet Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 25. Pet Vaccine Price by Manufacturers 2019-2024 (USD/Dose)
    Table 26. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Vaccine as of 2023)
    Table 28. Global Key Manufacturers of Pet Vaccine, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Pet Vaccine, Product Offered and Application
    Table 30. Global Key Manufacturers of Pet Vaccine, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 33. Global Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 34. Global Pet Vaccine Sales Share by Type (2019-2024)
    Table 35. Global Pet Vaccine Sales Share by Type (2025-2030)
    Table 36. Global Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 37. Global Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 38. Global Pet Vaccine Revenue Share by Type (2019-2024)
    Table 39. Global Pet Vaccine Revenue Share by Type (2025-2030)
    Table 40. Pet Vaccine Price by Type (2019-2024) & (USD/Dose)
    Table 41. Global Pet Vaccine Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 42. Global Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 43. Global Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 44. Global Pet Vaccine Sales Share by Application (2019-2024)
    Table 45. Global Pet Vaccine Sales Share by Application (2025-2030)
    Table 46. Global Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 47. Global Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 48. Global Pet Vaccine Revenue Share by Application (2019-2024)
    Table 49. Global Pet Vaccine Revenue Share by Application (2025-2030)
    Table 50. Pet Vaccine Price by Application (2019-2024) & (USD/Dose)
    Table 51. Global Pet Vaccine Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 52. US & Canada Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 53. US & Canada Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 54. US & Canada Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 55. US & Canada Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 56. US & Canada Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 57. US & Canada Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 58. US & Canada Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 59. US & Canada Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 60. US & Canada Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 61. US & Canada Pet Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 62. US & Canada Pet Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 63. US & Canada Pet Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 64. US & Canada Pet Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 65. Europe Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 66. Europe Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 67. Europe Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 68. Europe Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 69. Europe Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 70. Europe Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 71. Europe Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 72. Europe Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 73. Europe Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 74. Europe Pet Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 75. Europe Pet Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 76. Europe Pet Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 77. Europe Pet Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 78. China Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 79. China Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 80. China Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 81. China Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 82. China Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 83. China Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 84. China Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 85. China Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 86. Asia Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 87. Asia Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 88. Asia Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 89. Asia Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 90. Asia Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 91. Asia Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 92. Asia Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 93. Asia Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 94. Asia Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 95. Asia Pet Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 96. Asia Pet Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 97. Asia Pet Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 98. Asia Pet Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 99. Middle East, Africa and Latin America Pet Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America Pet Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America Pet Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pet Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Pet Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 104. Middle East, Africa and Latin America Pet Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 105. Middle East, Africa and Latin America Pet Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Pet Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 108. Middle East, Africa and Latin America Pet Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Pet Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Pet Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 111. Middle East, Africa and Latin America Pet Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 112. Bayer Healthcare Company Information
    Table 113. Bayer Healthcare Description and Major Businesses
    Table 114. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 115. Bayer Healthcare Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bayer Healthcare Recent Developments
    Table 117. Vetoquinol S.A Company Information
    Table 118. Vetoquinol S.A Description and Major Businesses
    Table 119. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 120. Vetoquinol S.A Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Vetoquinol S.A Recent Developments
    Table 122. Boehringer Ingelheim Company Information
    Table 123. Boehringer Ingelheim Description and Major Businesses
    Table 124. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 125. Boehringer Ingelheim Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Boehringer Ingelheim Recent Developments
    Table 127. Ceva Company Information
    Table 128. Ceva Description and Major Businesses
    Table 129. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 130. Ceva Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Ceva Recent Developments
    Table 132. Eli Lilly Company Information
    Table 133. Eli Lilly Description and Major Businesses
    Table 134. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 135. Eli Lilly Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Eli Lilly Recent Developments
    Table 137. Heska Co. Company Information
    Table 138. Heska Co. Description and Major Businesses
    Table 139. Heska Co. Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 140. Heska Co. Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Heska Co. Recent Developments
    Table 142. Merck Animal Health Company Information
    Table 143. Merck Animal Health Description and Major Businesses
    Table 144. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 145. Merck Animal Health Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Merck Animal Health Recent Developments
    Table 147. Merial (Sanofi) Company Information
    Table 148. Merial (Sanofi) Description and Major Businesses
    Table 149. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 150. Merial (Sanofi) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Merial (Sanofi) Recent Developments
    Table 152. Virbac Company Information
    Table 153. Virbac Description and Major Businesses
    Table 154. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 155. Virbac Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Virbac Recent Developments
    Table 157. Zoetis (Pfizer) Company Information
    Table 158. Zoetis (Pfizer) Description and Major Businesses
    Table 159. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 160. Zoetis (Pfizer) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Zoetis (Pfizer) Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Pet Vaccine Distributors List
    Table 165. Pet Vaccine Customers List
    Table 166. Pet Vaccine Market Trends
    Table 167. Pet Vaccine Market Drivers
    Table 168. Pet Vaccine Market Challenges
    Table 169. Pet Vaccine Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pet Vaccine Product Picture
    Figure 2. Global Pet Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pet Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Attenuated Live Vaccines Product Picture
    Figure 5. Conjugate Vaccines Product Picture
    Figure 6. Inactivated Vaccines Product Picture
    Figure 7. Subunit Vaccines Product Picture
    Figure 8. Toxoid Vaccines Product Picture
    Figure 9. DNA Vaccines Product Picture
    Figure 10. Recombinant Vaccines Product Picture
    Figure 11. Global Pet Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Pet Vaccine Market Share by Application in 2023 & 2030
    Figure 13. Canine
    Figure 14. Avian
    Figure 15. Feline
    Figure 16. Pet Vaccine Report Years Considered
    Figure 17. Global Pet Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Pet Vaccine Revenue 2019-2030 (US$ Million)
    Figure 19. Global Pet Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 20. Global Pet Vaccine Revenue Market Share by Region (2019-2030)
    Figure 21. Global Pet Vaccine Sales 2019-2030 ((K Doses)
    Figure 22. Global Pet Vaccine Sales Market Share by Region (2019-2030)
    Figure 23. US & Canada Pet Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 24. US & Canada Pet Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Pet Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 26. Europe Pet Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. China Pet Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 28. China Pet Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Asia (excluding China) Pet Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 30. Asia (excluding China) Pet Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. Middle East, Africa and Latin America Pet Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 32. Middle East, Africa and Latin America Pet Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 33. The Pet Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 34. The Top 5 and 10 Largest Manufacturers of Pet Vaccine in the World: Market Share by Pet Vaccine Revenue in 2023
    Figure 35. Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 36. Global Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 37. Global Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 38. Global Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 39. Global Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 41. US & Canada Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 42. US & Canada Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 43. US & Canada Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 44. US & Canada Pet Vaccine Revenue Share by Country (2019-2030)
    Figure 45. US & Canada Pet Vaccine Sales Share by Country (2019-2030)
    Figure 46. U.S. Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 47. Canada Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 48. Europe Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 49. Europe Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 50. Europe Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 51. Europe Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 52. Europe Pet Vaccine Revenue Share by Country (2019-2030)
    Figure 53. Europe Pet Vaccine Sales Share by Country (2019-2030)
    Figure 54. Germany Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 55. France Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 56. U.K. Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 57. Italy Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 58. Russia Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 59. China Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 60. China Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 61. China Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 62. China Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 64. Asia Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 65. Asia Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 66. Asia Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 67. Asia Pet Vaccine Revenue Share by Region (2019-2030)
    Figure 68. Asia Pet Vaccine Sales Share by Region (2019-2030)
    Figure 69. Japan Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 70. South Korea Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 71. China Taiwan Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 72. Southeast Asia Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 73. India Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 74. Middle East, Africa and Latin America Pet Vaccine Sales Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Pet Vaccine Revenue Market Share by Type (2019-2030)
    Figure 76. Middle East, Africa and Latin America Pet Vaccine Sales Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Pet Vaccine Revenue Market Share by Application (2019-2030)
    Figure 78. Middle East, Africa and Latin America Pet Vaccine Revenue Share by Country (2019-2030)
    Figure 79. Middle East, Africa and Latin America Pet Vaccine Sales Share by Country (2019-2030)
    Figure 80. Brazil Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 81. Mexico Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 82. Turkey Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 83. Israel Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 84. GCC Countries Pet Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 85. Pet Vaccine Value Chain
    Figure 86. Pet Vaccine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed